Steroids in pediatric eosinophilic esophagitis

Emily M. Contreras, Sandeep Gupta

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Swallowed fluticasone and oral viscous budesonide are effective first-line therapies for eosinophilic esophagitis in children. Side effects are minimal without evidence of Cushing syndrome, as seen in treatment with systemic corticosteroids. New studies on alternative delivery systems and different corticosteroids (eg, ciclesonide) are encouraging. As knowledge of corticosteroids in eosinophilic esophagitis expands, newer questions continue to arise concerning dose, delivery, and choice of corticosteroids; long-term adverse effects; and maintenance therapies.

Original languageEnglish
Pages (from-to)345-356
Number of pages12
JournalGastroenterology Clinics of North America
Volume43
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Eosinophilic Esophagitis
Adrenal Cortex Hormones
Steroids
Pediatrics
Budesonide
Cushing Syndrome
Therapeutics

Keywords

  • Budesonide
  • Children
  • Ciclesonide
  • Eosinophilic esophagitis
  • Fluticasone
  • Steroids
  • Topical steroids

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Steroids in pediatric eosinophilic esophagitis. / Contreras, Emily M.; Gupta, Sandeep.

In: Gastroenterology Clinics of North America, Vol. 43, No. 2, 2014, p. 345-356.

Research output: Contribution to journalArticle

@article{495e7d250b364494aaa4a03f49f9e294,
title = "Steroids in pediatric eosinophilic esophagitis",
abstract = "Swallowed fluticasone and oral viscous budesonide are effective first-line therapies for eosinophilic esophagitis in children. Side effects are minimal without evidence of Cushing syndrome, as seen in treatment with systemic corticosteroids. New studies on alternative delivery systems and different corticosteroids (eg, ciclesonide) are encouraging. As knowledge of corticosteroids in eosinophilic esophagitis expands, newer questions continue to arise concerning dose, delivery, and choice of corticosteroids; long-term adverse effects; and maintenance therapies.",
keywords = "Budesonide, Children, Ciclesonide, Eosinophilic esophagitis, Fluticasone, Steroids, Topical steroids",
author = "Contreras, {Emily M.} and Sandeep Gupta",
year = "2014",
doi = "10.1016/j.gtc.2014.02.008",
language = "English",
volume = "43",
pages = "345--356",
journal = "Gastroenterology Clinics of North America",
issn = "0889-8553",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Steroids in pediatric eosinophilic esophagitis

AU - Contreras, Emily M.

AU - Gupta, Sandeep

PY - 2014

Y1 - 2014

N2 - Swallowed fluticasone and oral viscous budesonide are effective first-line therapies for eosinophilic esophagitis in children. Side effects are minimal without evidence of Cushing syndrome, as seen in treatment with systemic corticosteroids. New studies on alternative delivery systems and different corticosteroids (eg, ciclesonide) are encouraging. As knowledge of corticosteroids in eosinophilic esophagitis expands, newer questions continue to arise concerning dose, delivery, and choice of corticosteroids; long-term adverse effects; and maintenance therapies.

AB - Swallowed fluticasone and oral viscous budesonide are effective first-line therapies for eosinophilic esophagitis in children. Side effects are minimal without evidence of Cushing syndrome, as seen in treatment with systemic corticosteroids. New studies on alternative delivery systems and different corticosteroids (eg, ciclesonide) are encouraging. As knowledge of corticosteroids in eosinophilic esophagitis expands, newer questions continue to arise concerning dose, delivery, and choice of corticosteroids; long-term adverse effects; and maintenance therapies.

KW - Budesonide

KW - Children

KW - Ciclesonide

KW - Eosinophilic esophagitis

KW - Fluticasone

KW - Steroids

KW - Topical steroids

UR - http://www.scopus.com/inward/record.url?scp=84899904781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899904781&partnerID=8YFLogxK

U2 - 10.1016/j.gtc.2014.02.008

DO - 10.1016/j.gtc.2014.02.008

M3 - Article

C2 - 24813520

AN - SCOPUS:84899904781

VL - 43

SP - 345

EP - 356

JO - Gastroenterology Clinics of North America

JF - Gastroenterology Clinics of North America

SN - 0889-8553

IS - 2

ER -